Top Health Tools
Top Health Tools

Top Reports
Top Reports
 
Top Articles
Top Articles

Top Reviews
Top Reviews
   
Report: 36 Canadians Suffer Severe
Allergic Reactions While 200 Others Died

British drugs giant GlaxoSmithKline has warned the Canadian medical authorities that a batch of its anti-H1N1 vaccine can trigger potentially dangerous allergic reactions.

The Canadians have withdrawn the batch from use and are testing it after it produced a range of serious reactions, notably in the heart and lungs. The recall affects 172,000 doses of the Arepanrix vaccine.

“We’ve been asked by the manufacturer GSK not to use this vaccine at this time pending further investigation,” said Manitoba chief medical officer Joel Kettner.

Thirty-six Canadians, including one little boy whose face swelled up like a balloon, suffered severe allergic reactions after vaccination. 200 others died.

Yet according to the Public Health Agency of Canada (PHAC) only 24 reactions and 1 death were documented.

“It is a serious thing that has the potential to kill – but fortunately seems to be relatively rare,” said Dr Neil Rau, an infectious disease specialist.

.* A full list of h1n1 vaccine ingredients, alerts and warnings.


Reference Source: euronews.net
November 27, 2009

Share/Bookmark
...............................................................................................................

This site is owned and operated by PreventDisease.com 1999-2014. All Rights Reserved. All content on this site may be copied, without permission, whether reproduced digitally or in print, provided copyright, reference and source information are intact and use is strictly for not-for-profit purposes. Please review our copyright policy for full details.
aaa
Interact
volunteerDonateWrite For Us
Stay Connected With Our Newsletter